Brevia Health’s Disease Profile Tracker offers unique insights into which diseases are being discussed by UK Parliamentarians and advocacy initiatives that can trigger interest. This includes awareness weeks and campaigns from patient groups and charities.
Our analysis tracks the Top 20 diseases by cause of mortality (as ranked by the Office for National Statistics’ monthly mortality analysis for England and Wales).[1]
The tracker highlights how some of the biggest causes of mortality do not receive comparable attention in the UK Parliament whilst other diseases get disproportionally more coverage.
Brevia Health has built a dataset which allows trends to be examined over the last five years and annual changes to be identified.
Five Key Developments in 2024
In 2024, the following have been identified:
- Covid-19 remained the most discussed disease in the UK Parliament in 2024, despite a 49 per cent decrease in mentions compared to 2023.
- Chronic lower respiratory diseases,[2] despite being the third biggest killer, only ranked eighth in the most discussed diseases in 2024.
- Diabetes was the fourth most mentioned disease in 2024 despite being the 19th leading cause of death.
- Breast cancer was the most discussed cancer in 2024 despite causing fewer deaths than lung cancer, colon cancer, and prostate cancer.
- Lung cancer saw a big drop in interest (down 32 per cent) in 2024 compared to 2023.
Brevia Health Insight
If you would like to find out more about Brevia Health’s disease tracker and how advocacy initiatives can be designed to drive political interest, please contact the Brevia Health team at contact@breviahealth.com.
Further insights will be released each month and key trends identified.
Notes
[1] The Office for National Statistics, ‘Monthly mortality analysis, England and Wales: December 2022’, link
[2] Chronic lower respiratory diseases include chronic obstructive pulmonary disease (COPD) and asthma.
